Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

7 results
Display

Another, A Few Good Device for End Stage Heart Failure

Lee J, Oh J, Kang SM

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Exploring the Role of Vitamin D Deficiency Correction in Heart Failure Management: Insights and Prospects

Kim HY

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Precision Cardiology: Phenotype-targeted Therapies for HFmrEF and HFpEF

Rosano GM, Vitale C, Spoletini I

Heart failure with mid-range ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF) represent over half of heart failure cases but lack proven effective therapies beyond sodium-glucose cotransporter 2 inhibitor and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vitamin D Deficiency in Patients Hospitalized for Heart Failure Living in the Tropics

Oliveira LBd, Siqueira MAdFM, Gadêlha RBdM, Garcia J, Bandeira F

Background and Objectives: Vitamin D, as a steroid hormone, has multiple effects on human body and its deficiency has been associated with an increased risk of heart failure (HF) and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Heart Failure Statistics 2024 Update: A Report From the Korean Society of Heart Failure

Lee CJ, Lee H, Yoon M, Chun KH, Kong MG, Jung MH, Kim IC, Cho JY, Kang J, Park JJ, Kim HC, Choi DJ, Lee J, Kang SM

Background and Objectives: The number of people with heart failure (HF) is increasing worldwide, and the social burden is increasing as HF has high mortality and morbidity. We aimed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Third Nationwide Korean Heart Failure III Registry (KorHF III): The Study Design Paper

Yoon M, Kim EJ, Han SW, Park SM, Kim IC, Cho MC, Ahn HS, Shin MS, Hwang SJ, Jeong JO, Yang DH, Kim JJ, Choi JO, Cho HJ, Yoo BS, Kang SM, Choi DJ

With advancements in both pharmacologic and non-pharmacologic treatments, significant changes have occurred in heart failure (HF) management. The previous Korean HF registries, namely the Korea Heart Failure Registry (KorHF-registry) and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adverse Events in Total Artificial Heart for End-Stage Heart Failure: Insight From the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE)

Tan MC, Yeo YH, Tham JW, Tan JL, Fong HK, Tan BEX, Lee KS, Lee JZ

Background and Objectives: Real-world clinical data, outside of clinical trials and expert centers, on adverse events related to the use of SyncCardia total artificial heart (TAH) remain limited. We aim...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr